<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD"><gtr:id>BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD</gtr:id><gtr:name>Salford Royal NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Cleveland House
Salford</gtr:line1><gtr:city>Greater Manchester</gtr:city><gtr:postCode>M6 8AL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Medical Statistics and Health Evaluation</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD"><gtr:id>BF056F42-5CA1-4C02-A8D3-AF6A9AA1A2FD</gtr:id><gtr:name>Salford Royal NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Cleveland House
Salford</gtr:line1><gtr:city>Greater Manchester</gtr:city><gtr:postCode>M6 8AL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4DD30DDB-46FD-464E-B1C5-B9895F852981"><gtr:id>4DD30DDB-46FD-464E-B1C5-B9895F852981</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Diggle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/78D2A13F-0E7D-4D3A-AB10-D2DC778DB73D"><gtr:id>78D2A13F-0E7D-4D3A-AB10-D2DC778DB73D</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Henderson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C5D38AFF-0D8F-4D11-B91B-7954A21AF259"><gtr:id>C5D38AFF-0D8F-4D11-B91B-7954A21AF259</gtr:id><gtr:firstName>Paula</gtr:firstName><gtr:surname>Williamson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400615"><gtr:id>A665DC83-11E6-4B95-A252-867598CF5479</gtr:id><gtr:title>Statistical Methodology for Longitudinal Studies in Clinical Research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400615</gtr:grantReference><gtr:abstractText>Progression of a disease or condition as it develops over time can be monitored in many ways, which can
be collectively referred to as biomarkers. Some of these are very familiar, such as blood pressure and cholesterol levels. Others are used to convert the results of tests and examinations into numerical scores, such as the stage of a cancer or a performance index of activity. Still others are the results of psychological questionnaires used to describe intangibles like mental health or quality of life.

This proposal aims to develop statistical methods to investigate how the patterns over time in biomarkers relate to prognosis for the patient and in particular the timing of clinically significant events. For example, we all know that a high cholesterol level leads to an increased risk of a heart attack, but is the risk for someone whose cholesterol level has risen gradually over several years the same as for someone whose cholesterol has increased to the same level in a much shorter time? And what about someone whose cholesterol has stayed constant at the same high level for many years? 

To answer questions like this we need to develop statistical models to describe the complex relationship between the biomarker and the clinical events. The models need to take into account errors in the measurement of the biomarker and the variability observed between people, so as to be able to detect genuine patterns in the type of data observed in practice. The models will be used to exploit biomarker data in providing accurate prognostic forecasts of clinical events, enabling identification of individuals in whom early intervention may be warranted to prevent adverse events. They will help the patient and their doctor to make the best treatment choice. The models can allow researchers to assess indirectly, but very quickly, the effect of a new drug or therapy, by examining its effect on biomarker patterns rather than waiting for the clinical event to occur. 

The proposal is built around three important medical areas: epilepsy treatment, cardio-thoracic surgery and renal transplantation. The multidisciplinary research team includes clinical specialists in each medical area as well as experienced statisticians from Liverpool and Lancaster Universities. Although there are currently no plans for direct communication to the public of the high level research methodology to be developed, specific medical results will be disseminated by collaborators through relevant Patient Association groups.</gtr:abstractText><gtr:technicalSummary>This proposal is for the development and application of
statistical methodology for longitudinal data which simultaneously include two components: event times and repeated measurements. Statistical methods for the proper treatment of data of this form are currently both under-developed and under-used in clinical research. An important aim of the programme is to develop user-friendly software to allow easy implementation of the methods to be developed, together with a series of workshops to provide training in the 
methodology and software.

The overall research programme will be built around specific collaborative research projects in three different medical areas: epilepsy treatment; cardio-thoracic surgery; and renal transplantation. As well as providing a range of clinical problems of interest in their own right, the three areas
together provide a range of study types on which to validate the methodology developed under the proposal.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>468248</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Salford Royal NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Longitudinal studies in renal medicine</gtr:description><gtr:id>00F84AF4-1FAB-44BF-8083-0A6C1EC6941E</gtr:id><gtr:impact>Hoefield, R.A., Kalra, P.A., Baker, P.G., Sousa, I., Diggle, P.J., Gibson, J.M., O'Donoghue,
D.J., Middleton, R.J. and New, J.P. (2011). The use of eGFR and ACR to predict decline
in renal function in people with diabetes. Nephrology Dialysis Transplantation, 26, 887-892</gtr:impact><gtr:outcomeId>ZNMAdMLCLZT-1</gtr:outcomeId><gtr:partnerContribution>Substantive knowledge of and research expertise in renal medicine, and provision of data</gtr:partnerContribution><gtr:piContribution>Development and application of statistical methods for longitudinal studies of renal function, with an initial focus on real-time prediction of renal failure from serial blood chemistry data</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited talk, London 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A634A261-0575-4104-A37E-9BF5A854E0F2</gtr:id><gtr:impact>75 participants attended the meeting from a range of institutes in UK and Europe that showed the potential of using novel methodology in clinical research. The talk was followed by a lively discussion.

More information on publications and software was requested (at the discussion, and by e-mail later) by several participants for their research.</gtr:impact><gtr:outcomeId>NMxog8Vfi3c</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Joint modelling talk, London 2013 RKD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>80AC8FFA-28F8-4008-8B6B-6E7BFFEFAC0C</gtr:id><gtr:impact>50-60 participants. The talk was followed by a lively discussion where participants discussed applying the methods in their clinical and biolomedical research.

Several participants approached to discuss their projects involving longitudinal data and requested the software JoineR.</gtr:impact><gtr:outcomeId>NfG12izZ6Qo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk, France 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7C666595-1DEA-4AA0-AA1B-AB19D5FFBC12</gtr:id><gtr:impact>Around 200 participants attended the meeting from all over the world. The talk was followed by a lively discussion about methodology and related software.

Several students/researchers requested information on software and also requested advise on their projects by e-mail afterwards.</gtr:impact><gtr:outcomeId>NkChqe164AE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>JoineR workshop 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4CA8557D-D9E2-47CE-8C67-881C69317C49</gtr:id><gtr:impact>A one-day training workshop was held on 13th September 2012 in Liverpool and 
discussed the novel statistical method through two expository lectures and gave practical instruction in the use of the software.

Very positive feedback received.</gtr:impact><gtr:outcomeId>RS9f5JQpWZf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Joint modelling talk, Budapest 2013 RKD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6D553EF6-39FA-40CF-A630-4B22983B94BF</gtr:id><gtr:impact>30-40 participants. The talk was followed by a lively discussion where participants discussed applying the methods in their clinical and biolomedical research.

Requests for the software JoineR.</gtr:impact><gtr:outcomeId>FmugRhNgpT4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>JoineR Workshop 2013, Newcastle RKD</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BD57ACB0-0DDC-408C-B1DB-F430EAA9C8CF</gtr:id><gtr:impact>13 participants. The workshop was interactive throughout where participants discuss applying the methods in their clinical data, and had hands-on experience in using the software JoineR.

The workshop has received very positive feedback. All participants considered use of joint modelling in their future research and improved their understanding of the relevance of joint modelling ideas to substantive clinical research.</gtr:impact><gtr:outcomeId>GfHjsPxvBRe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk, Birmimgham 2013 RKD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1796004F-A477-4EA3-B8E0-9AF78908277E</gtr:id><gtr:impact>150 participants. The talk was followed by a lively discussion.

Several participants approached to discuss their projects involving longitudinal biomarker data.</gtr:impact><gtr:outcomeId>MBQJVPu23Wi</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>42004</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology Research Panel</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>538FBB5F-BB91-4004-94DE-EBC03F8B0328</gtr:id><gtr:outcomeId>56c34093552583.51386417</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>229405</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research for Patient Benefit</gtr:department><gtr:description>Renehan A and Williamson PR (Joint PIs). Core outcome set for anal cancer studies</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>PB-PG-1013-32064</gtr:fundingRef><gtr:id>62E1E2D1-D255-4AA3-972E-1C0D657E51F0</gtr:id><gtr:outcomeId>58ad99c61523c8.43353091</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Shareware software to implement methods developed.</gtr:description><gtr:id>C060B31A-8623-493C-BA1A-E79D5968FE49</gtr:id><gtr:impact>Request for access from researchers.</gtr:impact><gtr:outcomeId>9817405E033</gtr:outcomeId><gtr:stage>Small-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Statistical software</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Joint modelling methods.</gtr:description><gtr:id>933DB04C-C53E-4E02-91F7-A80A53E2AA81</gtr:id><gtr:impact>Contacted by researchers requesting software to implement methods.</gtr:impact><gtr:outcomeId>192104BD4A4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New statistical methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EA5DA255-6FF7-4C83-8424-5AE9F5492211</gtr:id><gtr:title>Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ca0f3f11d7173d2fc36de42b6c82c49"><gtr:id>5ca0f3f11d7173d2fc36de42b6c82c49</gtr:id><gtr:otherNames>Taylor-Robinson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_540e13ce13c05c615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6B6D86D-F9FD-488B-AD30-BB10118623D6</gtr:id><gtr:title>A note on testing for intervention effects on binary responses.</gtr:title><gtr:parentPublicationTitle>Methods of information in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42e62215f51558491f67446aef9586f9"><gtr:id>42e62215f51558491f67446aef9586f9</gtr:id><gtr:otherNames>Friede T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0026-1270</gtr:issn><gtr:outcomeId>BFAE982AC25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0541190C-4308-4C00-BC51-4E9D5BE0367F</gtr:id><gtr:title>Depressive and manic symptoms are not opposite poles in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Acta psychiatrica Scandinavica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/473ad04466258d04a9eba623cd16be50"><gtr:id>473ad04466258d04a9eba623cd16be50</gtr:id><gtr:otherNames>Johnson SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-690X</gtr:issn><gtr:outcomeId>doi_55f9839838d18097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>369F424E-BA68-423D-B60B-8FDE9174DFCA</gtr:id><gtr:title>Joint Modeling of Time Series Measures and Recurrent Events and Analysis of the Effects of Air Quality on Respiratory Symptoms</gtr:title><gtr:parentPublicationTitle>Journal of the American Statistical Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>BBF49E3A2AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F61AD9C-7FF8-48F1-BF5F-02F82F162A74</gtr:id><gtr:title>Exploring changes in treatment effects across design stages in adaptive trials.</gtr:title><gtr:parentPublicationTitle>Pharmaceutical statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42e62215f51558491f67446aef9586f9"><gtr:id>42e62215f51558491f67446aef9586f9</gtr:id><gtr:otherNames>Friede T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1539-1604</gtr:issn><gtr:outcomeId>BB6311F7689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C042B276-A7CF-4FCE-8B46-125F51EA3F79</gtr:id><gtr:title>The use of eGFR and ACR to predict decline in renal function in people with diabetes.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e81d7218bab6d71b541e19b17f7764e"><gtr:id>5e81d7218bab6d71b541e19b17f7764e</gtr:id><gtr:otherNames>Hoefield RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>AYjasVX526m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECC1D8FB-C893-4F03-948A-EBC481B540F0</gtr:id><gtr:title>Joint modelling of longitudinal and competing risks data.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e134234ec325e4d0f2a665f60359eb6d"><gtr:id>e134234ec325e4d0f2a665f60359eb6d</gtr:id><gtr:otherNames>Williamson PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>A4B869E3096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCAF2E9F-5EA9-434E-BEC2-20A1F5173F67</gtr:id><gtr:title>A hidden Markov model for informative dropout in longitudinal response data with crisis states</gtr:title><gtr:parentPublicationTitle>Statistics &amp; Probability Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/544a652eb9f363614c9319ff8d2e038d"><gtr:id>544a652eb9f363614c9319ff8d2e038d</gtr:id><gtr:otherNames>Spagnoli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>LRbeGBTdhKt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF27917A-9D6C-42D1-A78A-64FB63FFE870</gtr:id><gtr:title>A relaxation of the gamma frailty (Burr) model.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5df44c4c744bdaeff04dfe8c44502e8f"><gtr:id>5df44c4c744bdaeff04dfe8c44502e8f</gtr:id><gtr:otherNames>Perperoglou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>EE624223915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21A14FA7-6334-4A3C-B472-6CC7EABD570E</gtr:id><gtr:title>Dynamic Analysis of Recurrent Event Data with Missing Observations, with Application to Infant Diarrhoea in Brazil</gtr:title><gtr:parentPublicationTitle>Scandinavian Journal of Statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/650ee53e0ef5a3b5ebbf25dcbf8d7aea"><gtr:id>650ee53e0ef5a3b5ebbf25dcbf8d7aea</gtr:id><gtr:otherNames>BORGAN ?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>6BF7B6861FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F098B33-27BB-49A9-8C10-B2DBBB0A6B83</gtr:id><gtr:title>Longitudinal study of the profile and predictors of left ventricular mass regression after stentless aortic valve replacement.</gtr:title><gtr:parentPublicationTitle>The Annals of thoracic surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b63ae21fba811c155e25441135d49dfd"><gtr:id>b63ae21fba811c155e25441135d49dfd</gtr:id><gtr:otherNames>Lim E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-4975</gtr:issn><gtr:outcomeId>20BA069BB0C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>114BC9A9-4F5E-4FF3-B431-0FBBCAEC0860</gtr:id><gtr:title>OPTIMAL DYNAMIC TREATMENT METHODS</gtr:title><gtr:parentPublicationTitle>REVSTAT-STATISTICAL JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61563c0e89658da1b92d5e3b770fcac4"><gtr:id>61563c0e89658da1b92d5e3b770fcac4</gtr:id><gtr:otherNames>Henderson Robin</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1645-6726</gtr:issn><gtr:outcomeId>L3EAv4nkjEz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FBC11BB-188C-41CA-978E-62098F74A853</gtr:id><gtr:title>Estimation of optimal dynamic anticoagulation regimes from observational data: a regret-based approach.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abfdba76b05011ebf4640815bf2106da"><gtr:id>abfdba76b05011ebf4640815bf2106da</gtr:id><gtr:otherNames>Rosth?j S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>4CCAEEB0D60</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F51721E2-DCCB-4264-935B-8F09CB800D66</gtr:id><gtr:title>Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a209535e7da79b5d62367bda05695b6"><gtr:id>4a209535e7da79b5d62367bda05695b6</gtr:id><gtr:otherNames>Taylor J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>pm_13169_19_19583779</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FD327FF-475D-4BC4-A754-102BDBFF1A18</gtr:id><gtr:title>Importance of competing risks in the analysis of anti-epileptic drug failure.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e134234ec325e4d0f2a665f60359eb6d"><gtr:id>e134234ec325e4d0f2a665f60359eb6d</gtr:id><gtr:otherNames>Williamson PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>26F1AF811CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5916280F-F8E5-4878-807C-82EC05CEFF5E</gtr:id><gtr:title>Analysis of longitudinal data with drop-out: objectives, assumptions and a proposal</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series C (Applied Statistics)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/615d0e6585286245ff1dd32dda9a15e3"><gtr:id>615d0e6585286245ff1dd32dda9a15e3</gtr:id><gtr:otherNames>Diggle P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>2FD2B0F9836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E620487-BCD3-4CC1-8153-676527AFA7F9</gtr:id><gtr:title>The influence of competing-risks setting on the choice of hypothesis test for treatment effect.</gtr:title><gtr:parentPublicationTitle>Biostatistics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e134234ec325e4d0f2a665f60359eb6d"><gtr:id>e134234ec325e4d0f2a665f60359eb6d</gtr:id><gtr:otherNames>Williamson PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1465-4644</gtr:issn><gtr:outcomeId>FFAE4C1CA71</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FF83E74-24BC-4A23-B3B9-D4FF995517B4</gtr:id><gtr:title>Comparative review of methods for handling drop-out in longitudinal studies.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc4ec632fd238da19722e528b7908836"><gtr:id>fc4ec632fd238da19722e528b7908836</gtr:id><gtr:otherNames>Philipson PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>C1C5F0CDC9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BAF3E6A-C5A1-43B3-B0DD-8F7405FD76FA</gtr:id><gtr:title>Effect and duration of lung volume reduction surgery: mid-term results of the Brompton trial.</gtr:title><gtr:parentPublicationTitle>The Thoracic and cardiovascular surgeon</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b63ae21fba811c155e25441135d49dfd"><gtr:id>b63ae21fba811c155e25441135d49dfd</gtr:id><gtr:otherNames>Lim E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0171-6425</gtr:issn><gtr:outcomeId>CC78C1A9158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED3557E0-502B-4CC9-B38D-91F4F73F3EAB</gtr:id><gtr:title>Exploratory analysis of longitudinal trials with staggered intervention times.</gtr:title><gtr:parentPublicationTitle>Biostatistics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31305c7303f9432928d51385c3699364"><gtr:id>31305c7303f9432928d51385c3699364</gtr:id><gtr:otherNames>Sousa I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1465-4644</gtr:issn><gtr:outcomeId>4F73889FBAC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E340878B-CB3D-43ED-AB79-8FEEB8B42739</gtr:id><gtr:title>Joint modelling of repeated measurements and time-to-event outcomes: the fourth Armitage lecture.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11a74d5a8836d8229edb92b26065ddc5"><gtr:id>11a74d5a8836d8229edb92b26065ddc5</gtr:id><gtr:otherNames>Diggle PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>260E54EF0CD</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400615</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>